Lifecore Biomedical, Inc. DE
LFCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001005286
No open-market purchases or sales by Lifecore Biomedical, Inc. DE insiders were filed in the last 90 days; 98 institutions reported holding it in 13F filings for Q2 2026, worth $133.3M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Lifecore Biomedical, Inc. DE as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- +5 vs. Q3 2025
- Shares held
- 24.8M
- +469.1K (+1.9%) vs. Q3 2025
- Total value
- $202.8M
- +$23.8M (+13.3%) vs. Q3 2025
- New holders
- 19
- 34 more added
- Sold out
- 14
- 26 more reduced
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LFCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 98 | $133.3M |
| Q1 2026 | 105 | $93.4M |
| Q4 2025 | 104 | $202.8M |
| Q3 2025 | 100 | $179.1M |
| Q2 2025 | 87 | $198.0M |
| Q1 2025 | 87 | $190.0M |
| Q4 2024 | 76 | $202.4M |
| Q3 2024 | 82 | $117.0M |
| Q2 2024 | 75 | $119.4M |
| Q1 2024 | 79 | $114.4M |
| Q4 2023 | 78 | $131.3M |
| Q3 2023 | 69 | $132.5M |
| Q2 2023 | 75 | $173.9M |
| Q1 2023 | 82 | $81.7M |
| Q4 2022 | 93 | $160.0M |
| Q3 2022 | 86 | $220.0M |
| Q2 2022 | 90 | $252.1M |
| Q1 2022 | 97 | $278.9M |
| Q4 2021 | 98 | $287.2M |
| Q3 2021 | 92 | $235.5M |
| Q2 2021 | 95 | $285.5M |
| Q1 2021 | 93 | $275.2M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Lifecore Biomedical, Inc. DE; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Greenhaven Road Investment Management, L.P. | 3,682,573 | $30.1M | 13.05% | −12,259−0.3% | Reduced |
| Legion Partners Asset Management, LLC | 4,461,823 | $36.5M | 21.25% | 00.0% | Unchanged |
| Wynnefield Capital Inc | 4,703,216 | $38.5M | 21.63% | 00.0% | Unchanged |
| 22NW, LP | 1,254 | – | – | 00.0% | Unchanged |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −37,822−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −29,964−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −29,038−100.0% | Sold out |
| Corsair Capital Management, L.P. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Tactive Advisors, LLC | 0 | $0 | 0.00% | −16,402−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −15,932−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −14,133−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −13,699−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −10,039−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −1,191−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −582−100.0% | Sold out |
| Halbert Hargrove Global Advisors, LLC | 0 | $0 | 0.00% | −230−100.0% | Sold out |
| SWAN Capital LLC | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| Corton Capital Inc. | – | – | – | – | Not filed |